# Safety of Transmucosal Capsaicin Sphenopalatine Ganglion Stimulation in Acute Ischemic Stroke

> **NCT07406971** · PHASE2 · RECRUITING · sponsor: **Instituto Mexicano del Seguro Social** · enrollment: 46 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Capsaicin Transmucosal Oral Film
- **DRUG:** Placebo Transmucosal Oral Film

## Key facts

- **NCT ID:** NCT07406971
- **Lead sponsor:** Instituto Mexicano del Seguro Social
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-10-31
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07406971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07406971, "Safety of Transmucosal Capsaicin Sphenopalatine Ganglion Stimulation in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07406971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*